Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: A view in 2013

Ying Wang, Linzhao Cheng, Sharon Gerecht

Research output: Contribution to journalArticle

Abstract

Human pluripotent stem cells (hPSCs) hold great promise for revolutionizing regenerative medicine for their potential applications in disease modeling, drug discovery, and cellular therapy. Many their applications require robust and scalable expansion of hPSCs, even under settings compliant to good clinical practices. Rapid evolution of media and substrates provided safer and more defined culture conditions for long-term expansion of undifferentiated hPSCs in either adhesion or suspension. With well-designed automatic systems or fully controlled bioreactors, production of a clinically relevant quantity of hPSCs could be achieved in the near future. The goal is to find a scalable, xeno-free, chemically defined, and economic culture system for clinical-grade expansion of hPSCs that complies the requirements of current good manufacturing practices. This review provides an updated overview of the current development and challenges on the way to accomplish this goal, including discussions on basic principles for bioprocess design, serum-free media, extracellular matric or synthesized substrate, microcarrier- or cell aggregate-based suspension culture, and scalability and practicality of equipment.

Original languageEnglish (US)
Pages (from-to)1357-1372
Number of pages16
JournalAnnals of Biomedical Engineering
Volume42
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Pluripotent Stem Cells
Stem cells
Cell culture
Suspensions
Regenerative Medicine
Serum-Free Culture Media
Bioreactors
Substrates
Drug Discovery
Scalability
Adhesion
Economics
Equipment and Supplies

Keywords

  • Cellular therapy
  • Clinical trials
  • Human pluripotent stem cells
  • Large-scale expansion

ASJC Scopus subject areas

  • Biomedical Engineering
  • Medicine(all)

Cite this

Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings : A view in 2013. / Wang, Ying; Cheng, Linzhao; Gerecht, Sharon.

In: Annals of Biomedical Engineering, Vol. 42, No. 7, 2014, p. 1357-1372.

Research output: Contribution to journalArticle

@article{caa45842d42a47d48b5808ddbfb74b4e,
title = "Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: A view in 2013",
abstract = "Human pluripotent stem cells (hPSCs) hold great promise for revolutionizing regenerative medicine for their potential applications in disease modeling, drug discovery, and cellular therapy. Many their applications require robust and scalable expansion of hPSCs, even under settings compliant to good clinical practices. Rapid evolution of media and substrates provided safer and more defined culture conditions for long-term expansion of undifferentiated hPSCs in either adhesion or suspension. With well-designed automatic systems or fully controlled bioreactors, production of a clinically relevant quantity of hPSCs could be achieved in the near future. The goal is to find a scalable, xeno-free, chemically defined, and economic culture system for clinical-grade expansion of hPSCs that complies the requirements of current good manufacturing practices. This review provides an updated overview of the current development and challenges on the way to accomplish this goal, including discussions on basic principles for bioprocess design, serum-free media, extracellular matric or synthesized substrate, microcarrier- or cell aggregate-based suspension culture, and scalability and practicality of equipment.",
keywords = "Cellular therapy, Clinical trials, Human pluripotent stem cells, Large-scale expansion",
author = "Ying Wang and Linzhao Cheng and Sharon Gerecht",
year = "2014",
doi = "10.1007/s10439-013-0921-4",
language = "English (US)",
volume = "42",
pages = "1357--1372",
journal = "Annals of Biomedical Engineering",
issn = "0090-6964",
publisher = "Springer Netherlands",
number = "7",

}

TY - JOUR

T1 - Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings

T2 - A view in 2013

AU - Wang, Ying

AU - Cheng, Linzhao

AU - Gerecht, Sharon

PY - 2014

Y1 - 2014

N2 - Human pluripotent stem cells (hPSCs) hold great promise for revolutionizing regenerative medicine for their potential applications in disease modeling, drug discovery, and cellular therapy. Many their applications require robust and scalable expansion of hPSCs, even under settings compliant to good clinical practices. Rapid evolution of media and substrates provided safer and more defined culture conditions for long-term expansion of undifferentiated hPSCs in either adhesion or suspension. With well-designed automatic systems or fully controlled bioreactors, production of a clinically relevant quantity of hPSCs could be achieved in the near future. The goal is to find a scalable, xeno-free, chemically defined, and economic culture system for clinical-grade expansion of hPSCs that complies the requirements of current good manufacturing practices. This review provides an updated overview of the current development and challenges on the way to accomplish this goal, including discussions on basic principles for bioprocess design, serum-free media, extracellular matric or synthesized substrate, microcarrier- or cell aggregate-based suspension culture, and scalability and practicality of equipment.

AB - Human pluripotent stem cells (hPSCs) hold great promise for revolutionizing regenerative medicine for their potential applications in disease modeling, drug discovery, and cellular therapy. Many their applications require robust and scalable expansion of hPSCs, even under settings compliant to good clinical practices. Rapid evolution of media and substrates provided safer and more defined culture conditions for long-term expansion of undifferentiated hPSCs in either adhesion or suspension. With well-designed automatic systems or fully controlled bioreactors, production of a clinically relevant quantity of hPSCs could be achieved in the near future. The goal is to find a scalable, xeno-free, chemically defined, and economic culture system for clinical-grade expansion of hPSCs that complies the requirements of current good manufacturing practices. This review provides an updated overview of the current development and challenges on the way to accomplish this goal, including discussions on basic principles for bioprocess design, serum-free media, extracellular matric or synthesized substrate, microcarrier- or cell aggregate-based suspension culture, and scalability and practicality of equipment.

KW - Cellular therapy

KW - Clinical trials

KW - Human pluripotent stem cells

KW - Large-scale expansion

UR - http://www.scopus.com/inward/record.url?scp=84904200925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904200925&partnerID=8YFLogxK

U2 - 10.1007/s10439-013-0921-4

DO - 10.1007/s10439-013-0921-4

M3 - Article

C2 - 24132657

AN - SCOPUS:84904200925

VL - 42

SP - 1357

EP - 1372

JO - Annals of Biomedical Engineering

JF - Annals of Biomedical Engineering

SN - 0090-6964

IS - 7

ER -